Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2003HepatologyOpen Access

Biochemical Surrogate Markers of Liver Fibrosis and Activity in A Randomized Trial of Peginterferon Alfa–2B and Ribavirin

View Full Paper
Ask AI
Bookmark
Share

Authors

TPThierry PoynardDélégation Paris 5John G. McHutchisonJohn G. McHutchisonHuman Genome Sciences (United States)MMM.P. MannsMedizinische Hochschule Hannover

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Poynard et al. (2003) studied this question.

synapsesocial.com/papers/6a6ff47b660549caf2c48071https://doi.org/10.1053/jhep.2003.50319
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial2002 · 223 citations
  2. 2Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C2002 · 89 citations
  3. 3Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients2003 · 205 citations
  4. 4Validation of the FibroTest Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients2003 · 244 citations
  5. 5Fibrosis in Patients with Chronic Hepatitis C: Detection and Significance2000 · 174 citations